Governance Viyash Scientific Limited

VIYASH

INE807F01027

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 05:00:50 2026-03-05 am EST			5-day change	1st Jan Change
202.05 ^INR	+0.37%		-8.16%	-2.93%

Feb. 13	Ruchira Papers Limited Announces Board and Committee Changes, Effective January 23 2026	CI
Feb. 06	Viyash Scientific Limited, Q3 2026 Earnings Call, Feb 06, 2026

Executive Committee: Viyash Scientific Limited

Manager

Positions heldSince

Haribabu Bodepudi

62 year

Chief Executive Officer

2025-12-15

Sirjiwan Singh

Chief Tech/Sci/R&D Officer

2018-12-31

Prasad Lad

Chief Administrative Officer	2013-12-31
Human Resources Officer	2013-12-31

Yoshita S. Vora

Compliance Officer	2024-12-16
Corporate Secretary	2024-12-16

Composition of the Board of Directors: Viyash Scientific Limited

Director

CommitteesSince

Kamal Kishore Sharma

78 year

Audit Committee
Compensation Committee
Nominating Committee

Milind Shripad Sarwate

66 year

Audit Committee	2019-03-31
Compensation Committee	2019-09-22
Nominating Committee	2019-09-22
Audit Committee Chair	2025-07-07
Compensation Committee Chair
Nominating Committee Chair

Anuj Poddar

51 year

Audit Committee	2025-09-04
Compensation Committee	2025-09-04
Nominating Committee	2025-09-04

Srinivas Vasireddy

Director/Board Member

2025-12-15

Haribabu Bodepudi

62 year

Director/Board Member

2023-08-06

Rajaram Narayanan

57 year

Director/Board Member

2022-04-10

Fabian Kausche

64 year

Director/Board Member

2020-12-13

Gregory Andrews

65 year

Director/Board Member

2020-11-05

Latest Appointments: Viyash Scientific Limited

Feb. 13	Ruchira Papers Limited Announces Board and Committee Changes, Effective January 23 2026	CI
Dec. 23	SeQuent Scientific Limited Announces Resignation of Ashish Kakabalia as Vice President - Business Development and Formulation Designated as Senior Management Personnel, Effective December 23, 2025	CI
Dec. 16	Sequent Scientific appoints Haribabu Bodepudi as managing director and group CEO	RE
Dec. 16	Sequent Scientific Limited Announces CFO Changes, Effective January 1, 2026	CI
Dec. 16	Sequent Scientific Limited Announces Key Managerial Personnel Changes, Effective January 1, 2026	CI
25-09-10	Sequent Scientific Limited Announces Resignation of Vedprakash Ragate as Whole- Time Director (Executive Director), Effective September 30, 2025	CI
25-09-05	Sequent Scientific Limited Announces Resignation of Mr. Neeraj Bharadwaj as Non-Executive, Non- Independent Director, Effective September 05, 2025	CI

More news

Former Officers and Directors: Viyash Scientific Limited

Insider

Positions held

SinceUntil

Saurav Bhala

Director of Finance/CFO

2023-11-05

2025-12-31

Ashish Kakabalia

Chief Tech/Sci/R&D Officer	-	-
Corporate Officer/Principal	-	2025-12-22

Neeraj Bharadwaj

Director/Board Member

2020-08-16

2025-09-04

Kausalya Santhanam

Director/Board Member	2014-10-27	2024-10-26
Independent Dir/Board Member	2014-10-27	2024-10-26

Krunal Shah

Compliance Officer	2019-11-12	2024-02-14
Investor Relations Contact	-	2024-02-14
Corporate Secretary	2019-11-12	2024-02-14

Venkat Raghavendra Patri

Director of Finance/CFO

2022-07-24

2023-10-24

Rahul Mukim

Director/Board Member

2020-08-16

2022-12-05

Tushar Pravinchandra Mistry

Compliance Officer	2019-06-28	2019-11-12
Director of Finance/CFO	2017-02-10	2022-05-30
Investor Relations Contact	-	-
Corporate Secretary	2019-06-28	2019-11-12

Manish Gupta

Director/Board Member	2014-11-21	2022-04-09
Chief Executive Officer	2014-11-11	2022-04-09

Gopakumar Gopalan Nair

Chairman	-	2020-08-24
Independent Dir/Board Member	-	2020-08-24

Shankarlal Devendra

Director/Board Member

2015-10-28

2020-08-16

K. E. C. Raja Kumar

Director/Board Member

2016-02-10

2020-08-16

Narendra Mairpady

Director/Board Member	2015-07-31	2020-07-30
Independent Dir/Board Member	2015-07-31	2020-07-30

Krupesh Mehta

Compliance Officer	2017-02-10	2019-06-28
Investor Relations Contact	2017-02-10	2019-06-28
Corporate Secretary	2017-02-10	2019-06-28

Preetham Hebbar

Compliance Officer	2013-03-31	2017-02-09
Investor Relations Contact	2013-03-31	2017-02-09
Corporate Secretary	2013-03-31	2017-02-09

P. R. Kannan

Director of Finance/CFO

2017-02-09

Sharat Pandu Rang Narasapur

Director/Board Member	2017-01-07	-
Chief Executive Officer	2017-01-07	-
Corporate Officer/Principal	2017-01-07	2024-04-29

Kannan Ramanujam

Director/Board Member	-	2016-02-10
Independent Dir/Board Member	-	2016-02-10

Gautam Kumar Das

Director/Board Member	2010-01-26	-
Chief Executive Officer	2010-01-06	-
Corporate Officer/Principal	2010-01-06	-

Deepak Calian Vaidya

Chairman

2010-06-14

Keerthapati Ramaraju Ravishankar

Director/Board Member	2010-06-14	2012-03-26
Chief Executive Officer	2012-03-26	2014-09-28
Chairman	2009-10-28	2014-09-28

Arun Kumar

President

2010-06-14

Vinayak Hegde

Corporate Secretary

Arun Pillai

Founder

Pallipuram Mathai Thampi

Director/Board Member

2010-06-14

Arun N. Kumar

Founder

Age distribution of managers

Parity Men Women

Male	11
Female	0

Of which Executive Committee

Male	4
Female	0

Of which Directors

Male	8
Female	0

SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. The Companyâ€™s subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.

Employees

1,244

Sector

Pharmaceuticals

More about the company